Patent · US Active

Separation matrix

US10711035B2 · kind B2 · utility

12Cited by

77References

31Claims

0Family size

Assignee

GE Healthcare BioProcess R&D AB · SE

Inventors

Gustav Rodrigo · Uppsala, SE
Tomas Bjorkman · Uppsala, SE
Mats Ander · Uppsala, SE
Jesper Ulf Hansson · Uppsala, SE

Key dates

Filing date	Nov 13, 2019
Grant date	Jul 14, 2020
Priority date	—
Expiry date	Nov 13, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K17/10
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

The invention relates to a separation matrix comprising at least 11 mg/ml Fc-binding ligands covalently coupled to a porous support, wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.